CAPULLI, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 81
NA - Nord America 41
AS - Asia 14
Totale 136
Nazione #
IE - Irlanda 41
US - Stati Uniti d'America 41
IT - Italia 21
FR - Francia 18
VN - Vietnam 14
DE - Germania 1
Totale 136
Città #
Dublin 41
Ashburn 14
Dong Ket 14
Boardman 11
San Jose 7
L'aquila 6
L’Aquila 5
Milan 3
Pescara 3
Paris 2
Bologna 1
Bremen 1
Norwalk 1
Palo Alto 1
Redmond 1
Seattle 1
Totale 112
Nome #
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications, file e2188bfa-c23e-f28d-e053-d805fe0ac2bb 16
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis, file e2188bfa-c89f-f28d-e053-d805fe0ac2bb 16
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation, file e2188bfa-cbeb-f28d-e053-d805fe0ac2bb 16
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk, file e2188bfa-d16c-f28d-e053-d805fe0ac2bb 15
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry, file e2188bfa-b63b-f28d-e053-d805fe0ac2bb 13
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM, file e2188bfa-cb70-f28d-e053-d805fe0ac2bb 11
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development, file e2188bfa-e7d6-f28d-e053-d805fe0ac2bb 11
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2, file e2188bfa-cbed-f28d-e053-d805fe0ac2bb 10
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2, file e2188bfa-cbef-f28d-e053-d805fe0ac2bb 10
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice, file e2188bfa-b63f-f28d-e053-d805fe0ac2bb 6
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis, file e2188bf8-ffac-f28d-e053-d805fe0ac2bb 2
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine, file e2188bfb-31ea-f28d-e053-d805fe0ac2bb 2
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice, file e2188bf9-05c6-f28d-e053-d805fe0ac2bb 1
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature", file e2188bf9-0e38-f28d-e053-d805fe0ac2bb 1
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression, file e2188bf9-7546-f28d-e053-d805fe0ac2bb 1
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis., file e2188bfa-c936-f28d-e053-d805fe0ac2bb 1
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study, file e2188bfa-cbf3-f28d-e053-d805fe0ac2bb 1
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development, file e2188bfa-d7aa-f28d-e053-d805fe0ac2bb 1
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development, file e2188bfa-d7ab-f28d-e053-d805fe0ac2bb 1
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development, file e2188bfb-40a7-f28d-e053-d805fe0ac2bb 1
Totale 136
Categoria #
all - tutte 411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 3 0 0 0 0 0 0
2020/202123 0 0 0 0 0 0 0 6 0 3 0 14
2021/20222 0 0 0 0 0 0 0 1 0 0 1 0
2022/202379 0 0 0 0 1 1 0 0 41 0 36 0
2023/202425 0 0 0 0 4 0 10 11 0 0 0 0
Totale 136